IN THE NEWS: How Does CLL Inhibit Immune Function?

Patient Power

Chronic lymphocytic leukemia (CLL) accounts for about 25-30% of leukemia cases in the U.S. Abhinav Deol, M.D., hematologist, medical oncologist, and member of the Bone Marrow and Stem Cell TransplantHematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, explained what CLL is, the effect this cancer can have on the immune system, and how CLL patients can protect themselves during flu season.

Read the article here.

Abhinav Deol, M.D.